Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is a leading player in the global pharmaceutical industry, headquartered in the United States. Founded in 1953, the company has made significant strides in various therapeutic areas, including oncology, immunology, neuroscience, and infectious diseases. With a commitment to innovation, Janssen is renowned for its core products, such as innovative treatments for cancer and autoimmune disorders, which are distinguished by their efficacy and safety profiles. The company has achieved notable milestones, including the development of groundbreaking therapies that have transformed patient care. Janssen's strong market position is underscored by its extensive research and development efforts, which continue to drive advancements in medicine, making it a trusted name in healthcare worldwide.
We don't have data for Janssen, but we can show you information about their parent organization instead.
View parent company